We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Polarean Imaging Plc | LSE:POLX | London | Ordinary Share | GB00BF3DT583 | ORD GBP0.00037 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.025 | 1.64% | 1.55 | 1.50 | 1.60 | 1.625 | 1.55 | 1.60 | 9,184,566 | 15:58:24 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Surgical,med Instr,apparatus | 891k | -11.89M | -0.0098 | -1.58 | 18.41M |
Date | Subject | Author | Discuss |
---|---|---|---|
26/9/2024 18:36 | Also AGL fell from a £50m mcap now to like £25mcap. Watch it bounce back up again as always. POLX meanwhile is at a lowly £18mcap, barelt pricing in the cash and technology and revenues. Not only that the board are giving much more conservative guidance which so far it has delivered on, which is why when the interim results came a few weeks ago the price went UP. Unlike rampy Newland at Angle who consistent over promises and under delivers and thus a dump today. Not only that but POLX is set to have comparable revenues to ANGLE from a much lower market cap all whilst have more cash in the bank AND technology that is an easier sell to the clinical sites and they are coming in their droves. From 1.5p I fancy 5-6p EOY for POLX. | m_night10 | |
26/9/2024 18:30 | Hard disagree here for multiple reasons. -They have cash until AT LEAST Q1 2026 and as revenue guidance is increasing, as are orders and costs have been reduced already (read the report), I think it's likely the case runway will extend into Q2/Q3 2026, so nearly 2 years from now. -Revenues are going to be up to 3,000% in 2024 over 2023 (read the report) -Cash on hand almost = current mcap -The tech is FDA approved -The tech has seen a massive uptick in adoption this year -They have just hired many big names for the sales team to ramp up sales -The technology is important and isn't priced in the market cap when factoring the above -The share price is 1.5p and before all of this it touched 100p -I see a great recover play from here, either to the gap at 3.4p or higher on fundamentals. Not advice and DYOR. | m_night10 | |
26/9/2024 18:02 | Agree someone is dumping this and it's spending way too much money . The last fund raise should have seen huge cost cutting to slash the losses until revenue grew but they didn't and so it's going to be another raise needed well before they get to break even . Of all the ones that have been hit with huge dillution this is the one I like least as it's simply making losses that are to big given the situation | bones698 | |
26/9/2024 11:01 | Strong SELL It will go down like AGL If you want a gamble VAST RESOURCES | riskyinvestor | |
26/9/2024 09:22 | Or after a bid or collaboration announcement ! It won’t be small I’m hearing | washingmachine | |
26/9/2024 09:17 | For me the webinar with questions is the start of a new chapter for polx, proper communication with ALL shareholders .... | slicethepie | |
26/9/2024 07:45 | Doesn't take a rocket scientist to see we are at the start of the up cycle within the trading margin of last few months | moontheloon | |
26/9/2024 07:41 | As usual good luck all holders, the places like British bulls only accentuate movements up and down currently buy after stay short for the dip which kinda self fulfils on low volume. Which is one of reasons we will find it hard to break 1.9 without anymore news | moontheloon | |
25/9/2024 17:00 | If your talking about me Loon then your are incorrect i have many investment in companies that ive never posted on. Just because i dont post doesn't mean 2 say i dont hold. | john henry | |
25/9/2024 16:36 | When people like you arrive we know there's a trade on... then you'll disappear | moontheloon | |
25/9/2024 11:47 | Tick incoming | moontheloon | |
25/9/2024 11:05 | john henry STX Put it on your WATCHLIST Since FDA approval their turnover is going rapid | riskyinvestor | |
25/9/2024 10:46 | Be 1.6 on the mid very soon. | moontheloon | |
25/9/2024 10:40 | If you did and stay long term fair enough. The long term is very compelling from this price | moontheloon | |
25/9/2024 10:14 | 1.6 upwards today. There was no reason for the dip below.maybe global scenario... some get rattled and move to cash. Only good coming from the company. | moontheloon | |
25/9/2024 10:11 | So much for you saying you were a long term holder. You will always be just a trader JH. Repect the company and it's prospects don't be a parasite | moontheloon | |
25/9/2024 10:05 | 223,416 lasted 14 minutes LOL | john henry | |
25/9/2024 09:29 | Traders Been waiting. If only I had spare funds was desperate to add at 1.49pAh well as long it's going in the right direction this was stupid level. Absolute no brainer investment level! | moontheloon | |
25/9/2024 09:18 | some decent buying volume added | john henry | |
25/9/2024 06:24 | Should be very beneficial and give even more insight. | moontheloon | |
25/9/2024 06:23 | Polarean Imaging plc("Polarean" or the "Company") Virtual Investor Day Polarean Imaging plc (AIM: POLX), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging ("MRI") of lung function, announces it will be hosting a virtual investor day on Wednesday 9 October 2024, at 2.00pm BST / 9.00am EST. The event will be held via a Zoom webinar and will feature presentations on Polarean's lung functional Xenon MRI platform, its clinical use and future utility, as well as the Company's commercial strategy and future plans. The event is open to all. A welcome and introduction will be given by Christopher von Jako, Ph.D., CEO of Polarean Imaging. The afternoon will also feature presentations by: · Dr. Chase Hall, Chief Medical Advisor· Dr. Bastiaan Driehuys, Chief Scientific Officer and founder of Polarean· Alex Dusek, Chief Commercial Officer The presentations will be followed by a Q&A session where attendees can submit questions to the management team. To register for the webinar, please use this link: Webinar Registration - Zoom Enquiries | moontheloon | |
19/9/2024 12:38 | This needs some positive news ,unfortunately it's very slow in coming as usual . | bones698 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions